Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling FAM111B: A Pan-Cancer Biomarker for DNA Repair and Immune Infiltration

28 Mar 2025

Abstract excerpt

Recent evidence indicates that FAM111B is significantly involved in the progression of various cancers. Nonetheless, the potential pan-cancer implications of FAM111B have not been systematically investigated. In this study, FAM111B's expression and oncogenic potential were studied using TCGA and GTEx data via GEPIA2, TIMER2.0, and STRING tools. Pathway enrichment analyses with the GO, KEGG, Reactome, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40243892
DOI: 10.3390/ijms26073151

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling FAM111B: A Pan-Cancer Biomarker for DNA Repair and Immune InfiltrationPMID 40243892Read ↗

Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read ↗

Potential Value of PRKDC as a Therapeutic Target and Prognostic Biomarker in Pan-CancerSemantic proximity Read ↗

A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancerSemantic proximity Read ↗

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancerSemantic proximity Read ↗

Prognostic and immunological role of FDX1 in pan-cancer: an in-silico analysisSemantic proximity Read ↗

A comprehensive pan-cancer analysis identifies AP1S1 as a novel biomarker for predicting prognosis and immunotherapy responseSemantic proximity Read ↗

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

Pan-cancer analysis of DEFB1 as a candidate prognostic biomarker and associated with immune infiltrationSemantic proximity Read ↗

Cyclin B1: A potential prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

KIF11 As a Potential Pan‐Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic ResponsesSemantic proximity Read ↗

FAM111B enhances proliferation of <i>KRAS</i>‐driven lung adenocarcinoma by degrading p16Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.